Cystic fibrosis: Current treatment and promise for the future

R. J. Kuhn, D. R. Butler

Research output: Contribution to journalShort surveypeer-review


With our increasing knowledge base and the promise of several new advances in drug therapy in the near future, most clinicians will take a more aggressive approach with early drug treatment in CF. Patients will probably start receiving antimicrobial therapy earlier, and as new therapies become available (i.e, rhDNase, aerosolized amiloride), patients with CF will be evaluated earlier in the course of the disease to assess the potential benefit of these agents. Drug therapy for patients with CF will increase in complexity during the next few years. The expertise of pharmacists will be required to help educate these patients and to manage their drug treatment regimen. Life expectancy of the patient with CF will continue to increase, and by the end of the decade, definitive therapy for this disease will probably be exist.

Original languageEnglish
Pages (from-to)51-58
Number of pages8
JournalAmerican Druggist
Issue number4
StatePublished - 1994

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Cystic fibrosis: Current treatment and promise for the future'. Together they form a unique fingerprint.

Cite this